| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 444.275 | 91 |
| GSM780708 | Untreated after 4 days (C2_1) | 338.418 | 88 |
| GSM780709 | Untreated after 4 days (C3_1) | 376.506 | 89 |
| GSM780719 | Untreated after 4 days (C1_2) | 464.395 | 91 |
| GSM780720 | Untreated after 4 days (C2_2) | 370.319 | 89 |
| GSM780721 | Untreated after 4 days (C3_2) | 398.891 | 90 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 380.076 | 89 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 407.446 | 90 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 370.245 | 89 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 359.493 | 89 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 466.977 | 91 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 380.076 | 89 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 430.419 | 90 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 335.837 | 88 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 402.815 | 90 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 492.298 | 91 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 378.628 | 89 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 405.899 | 90 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 417.021 | 90 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 419.97 | 90 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 377.686 | 89 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 450.042 | 91 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 422.633 | 90 |